Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2019; 15
DOI: 10.1055/s-0044-1797842
E-PÔSTER
TEMÁRIO: ONCOMASTOLOGIA

INTERPECTORAL ANESTHETIC BLOCK (PEC) IN RADICAL MASTECTOMIES WITH AXILLARY APPROACH: AN ALTERNATIVE TO PAIN CONTROL IN AN ONCOLOGY SURGERY SERVICE IN MACEIÓ

Amanda Lira dos Santos Leite
1   Santa Casa de Misericórdia de Maceió
,
Frederico Theobaldo Ramos Rocha
1   Santa Casa de Misericórdia de Maceió
,
Aldo Vieira Barros
1   Santa Casa de Misericórdia de Maceió
,
Claudemiro de Castro Meira Neto
1   Santa Casa de Misericórdia de Maceió
,
Robério Silva Melo
1   Santa Casa de Misericórdia de Maceió
,
Diego Windson de Araújo Silvestre
1   Santa Casa de Misericórdia de Maceió
,
Tainá Santos Bezerra
1   Santa Casa de Misericórdia de Maceió
,
Thiago Yamamoto Amaral
1   Santa Casa de Misericórdia de Maceió
,
Alberson Maylson Ramos da Silva
1   Santa Casa de Misericórdia de Maceió
,
Elson Alexandro Cordeiro Folha Filho
1   Santa Casa de Misericórdia de Maceió
› Author Affiliations
 

    Introduction: Patients undergoing mastectomies with axillary dissection suffer greatly from postoperative pain and discomfort, so sought to study regional blockade techniques that could minimize such effect, such as Interpectoral block (PEC). This innovative technique can become an analgesic option widely used in axillary surgery due to the low complication rate and the single puncture characteristic technique that allows simultaneous blockade of various dermatomes, reducing postoperative pain and The abusive use of opioids and their complications. Objectives: To disclose the anesthetic blockade technique performed in an oncologic surgery service, in order to expose alternatives for postoperative pain control in mastectomy patients. Method: PEC blockade performed after general anesthesia induced with fentanyl and Propofol and in maintenance with Sevoflurane and Remifentanil in infusion pump. Ultrasoundguided technique with injection of levobupivacaine with vasoconstrictor in the concentration of 0.37%, with infiltration of 10ml between pectoral muscles and 20ml between the pectoral minor and the sawdust muscle, followed by the surgical incision. All patients are evaluated in the postoperative period by the pain scale and receive prescription of dipyrone and/or tramadol, administered if necessary to not mask the level of pain. Results: The main study showing that the PEC blockade reduces postoperative pain after mastectomies with axillary approach, minimizing the use of opioids and their complications, was published by Blanco in 2011. In 2018 it was implanted in this referral service in oncological surgery of Maceió with good postoperative response and evidence of better satisfaction of patients with pain control after analysis of the EVA scale available postoperatively. Conclusion: The pectoral block technique (PEC) is easy to perform and feasible with better pain control of patients in the postoperative period of radical mastectomies with axillary approach.


    No conflict of interest has been declared by the author(s).

    Contato:

    Amanda Lira dos Santos Leite

    Publication History

    Article published online:
    23 October 2019

    © 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

    Bibliographical Record
    Amanda Lira dos Santos Leite, Frederico Theobaldo Ramos Rocha, Aldo Vieira Barros, Claudemiro de Castro Meira Neto, Robério Silva Melo, Diego Windson de Araújo Silvestre, Tainá Santos Bezerra, Thiago Yamamoto Amaral, Alberson Maylson Ramos da Silva, Elson Alexandro Cordeiro Folha Filho. INTERPECTORAL ANESTHETIC BLOCK (PEC) IN RADICAL MASTECTOMIES WITH AXILLARY APPROACH: AN ALTERNATIVE TO PAIN CONTROL IN AN ONCOLOGY SURGERY SERVICE IN MACEIÓ. Brazilian Journal of Oncology 2019; 15.
    DOI: 10.1055/s-0044-1797842